Topics

DE-INTENSIFICATION OF DIABETES TREATMENT IN ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS.

08:00 EDT 14th August 2019 | BioPortfolio

Summary of "DE-INTENSIFICATION OF DIABETES TREATMENT IN ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS."

De-intensification of diabetes treatment is recommended in elderly patients with tight glycemic control at high risk of hypoglycemia. However, rates of de-intensification in endocrine practice are unknown. We conducted a retrospective study to evaluate the rate of de-intensification of anti-diabetic treatment in elderly patients with type 2 diabetes mellitus (T2DM) and tight glycemic control.

Affiliation

Journal Details

This article was published in the following journal.

Name: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
ISSN: 1530-891X
Pages:

Links

DeepDyve research library

PubMed Articles [45936 Associated PubMed Articles listed on BioPortfolio]

Longitudinal Changes in HbA1c following Therapy Intensification after Inadequate Response to Two Oral Antidiabetic Agents in Patients with Type 2 Diabetes in Germany.

In their U.S. study, Kim et al. have shown based on 1,226 type 2 diabetes patients that the intensification following A1c ≥7.0% on 2OADs was associated with a significant improvement in glycemic con...

Oral diabetes medication and risk of dementia in elderly patients with type 2 diabetes.

To examine the effect of oral diabetes medication on the risk of dementia in an elderly cohort with type 2 diabetes.

The Impact on Glycemic Control Through Progressive Resistance Training with bioDensity in Chinese Elderly Patients with Type 2 Diabetes: The PReTTy2 (Progressive Resistance Training in Type 2 Diabetes) Trial.

To evaluate the effects of a novel, low-volume, high-intensity Progressive Resistance Training (PRT) technique on blood glucose control in elderly Chinese patients with Type 2 Diabetes.

Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus.

Early treatment intensification for type 2 diabetes mellitus (T2DM) is often required to achieve glycaemic control and avoid longer-term complications. We assessed associations between early versus la...

Efficacy and safety of Cinnamon in Type 2 Diabetes Mellitus and Pre-diabetes patients: A Meta-analysis and Meta-regression.

Cinnamon has been used as a dietary component and in the management of diabetes mellitus. This study systematically reviewed and synthesized evidence on the efficacy of cinnamon for the treatment of t...

Clinical Trials [14893 Associated Clinical Trials listed on BioPortfolio]

Sitagliptin in the Elderly

Diabetes is common in the elderly; by the age of 70, approximately 25% of the population will have diabetes. Unfortunately, currently available medications are often not as effective or ...

Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes

The results from the DECODE Study have shown that postprandial (1 - 2 hours after a meal) hyperglycemia (elevated blood sugar) is more common in elderly people with diabetes than younger p...

A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes

This trial is conducted in Europe. The aim of this clinical trial is to investigate the blood glucose lowering effect of NN1250 in young and elderly subjects with type 1 diabetes.

Cohort Study of Patients With Type 1 Diabetes

This study aims to clarify the underlying hereditary and autoimmune factors that contribute to clinical type 1 diabetes and gain a better understanding of the natural history of the diseas...

Autoimmune Diabetes: Markers of the Disease and Treatment of Latent Autoimmune Diabetes of the Adults (LADA)

Autoimmunity is the main cause of diabetes type 1 and an important factor as cause of LADA. Recently, research have found that being deficient of T-reg cells is an important cause of autoi...

Medical and Biotech [MESH] Definitions

A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).

Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes (DIABETES MELLITUS; DIABETES INSIPIDUS).

The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy.

Excessive thirst manifested by excessive fluid intake. It is characteristic of many diseases such as DIABETES MELLITUS; DIABETES INSIPIDUS; and NEPHROGENIC DIABETES INSIPIDUS. The condition may be psychogenic in origin.

Quick Search


DeepDyve research library

Searches Linking to this Article